(CIDRAP News) – A five-country study from Europe indicates that the use of adjuvanted vaccines against the pandemic H1N1 influenza virus probably did not increase the risk of Guillain-Barre syndrome (GBS), but the investigators could not firmly rule out a slightly greater chance of suffering the paralytic condition.
(CIDRAP News) The price-tag for federal investments in new flu vaccine technology has been difficult to get a handle on, but yesterday in a review for Congress the Government Accountability Office (GAO) put the number at $2.1 billion since fiscal year 2005.
(CIDRAP News) A report released yesterday by the Government Accountability Office (GAO) offers yet another review of lessons from the federal government's response to the H1N1 influenza pandemic while detailing how the government spent, and is still spending, $6.15 billion that was appropriated for the response.
Jun 27, 2011
Jun 2, 2011
(CIDRAP News) At the World Health Assembly (WHA) in Geneva today, the full group adopted a review of the World Health Organization's (WHO's) performance during the 2009 H1N1 pandemic, while a committee made some last-minute changes to a framework for sharing flu viruses.
